PHL 612 Neuropharmacology-I

PHL 612 Neuropharmacology-I

ملحقات المادة الدراسية

PHL 425 Pharmacology-IV

PHL 425 Pharmacology-IV

ملحقات المادة الدراسية

495 Undergraduate research project

495 Undergraduate research project

ملحقات المادة الدراسية

PHL 618 PhD Student Lab Rotation

PHL 618 PhD Lab Rotation

ملحقات المادة الدراسية

PHL 533 Neuropharmacology-I

PHL 533 Neuropharmacology-I

ملحقات المادة الدراسية

PHL 322 Pharmacology-II

PHL 322 Pharmacology-II

ملحقات المادة الدراسية

Fibroblast Growth Factor 14 is an Essential Element of the Inhibitory Circuit that Controls Cognitive Function Associated with Schizophrenia

Cognitive processes require gamma-amino-butyric acid (GABA) interneurons. Via complex synaptic connections, these cells regulate cellular excitability and synaptic plasticity of principal neurons, balancing the excitatory/inhibitory (E/I) tone in cortical networks. Loss of and impairment in function of parvalbumin (PV) interneurons and GABAergic synapses is associated with cognitive impairment in schizophrenia and other psychiatric disorders. Despite efforts to identify the molecular factors leading to E/I imbalance and impaired PV interneuron functioning, much remains to be learned.

Purkinje cell synaptic impairment in a mouse model of spinocerebellar ataxia type 27

Genetically inherited mutations in the fibroblast growth factor 14 (FGF14) gene lead to spinocerebellar ataxia type 27 (SCA27), an autosomal dominant disorder characterized by heterogeneous motor and cognitive impairments. Consistently, genetic deletion of Fgf14 in Fgf14−/− mice recapitulates salient features of the SCA27 human disease.

الصفحات

اشترك ب KSU Faculty آر.إس.إس